ArticleThe American journal of tropical medicine and hygiene2020
Artemether-Lumefantrine Efficacy for the Treatment of Uncomplicated
Article in The American journal of tropical medicine and hygiene, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 27 citations in OpenAlex.
- Effectiveness and safety of artesunate-amodiaquine versus artemether-lumefantrine for home-based treatment of uncomplicated Plasmodium falciparum malaria among children 6-120 months in Yaoundé, Cameroon: a randomized trial.BMC infectious diseases · 2022Trial
- Computational Analysis of Plasmodium falciparum DNA Damage Inducible Protein 1 (PfDdi1): Insights into Binding of Artemisinin and its Derivatives and Implications for Antimalarial Drug Design.Cell biochemistry and biophysics · 2025Article
- Tracking Drug Resistance inInternational journal of molecular sciences · 2025Article
- Molecular Surveillance of Artemisinin-ResistantInternational journal of environmental research and public health · 2024Article
- Changes in the endemic-epidemic pattern of malaria in Colombia, 1978-2021.Revista da Sociedade Brasileira de Medicina Tropical · 2024Article
- Perception and awareness towards malaria vaccine policy implementation in Nigeria by health policy actors.Malaria journal · 2023Article
- Molecular surveillance for anti-malarial drug resistance and genetic diversity of Plasmodium falciparum after chloroquine and sulfadoxine-pyrimethamine withdrawal in Quibdo, Colombia, 2018.Malaria journal · 2022Article
- Article
- Stakeholder perceptions on the deployment of multiple first-line therapies for uncomplicated malaria: a qualitative study in the health district of Kaya, Burkina Faso.Malaria journal · 2022Article
- Malaria epidemics in Colombia, 1970-2019.Revista da Sociedade Brasileira de Medicina Tropical · 2022Article
- Kelch13 mutations in Plasmodium falciparum and risk of spreading in Amazon basin countries.The Journal of antimicrobial chemotherapy · 2021Article
- Malaria risk stratification in Colombia 2010 to 2019.PloS one · 2021Article
- Malaria mortality in Colombia from 2009 to 2018: a descriptive study.Revista da Sociedade Brasileira de Medicina Tropical · 2021Article
- Parasite density in severe malaria in Colombia.PloS one · 2020Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors at 7 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Artemether-lumefantrine (AL) is the first-line treatment for uncomplicated
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.